Patent Yard Sign in
Expired Canadian patentCanada

Prodrug derivatives of carboxylic acid drugs

CA 1325422 C · Owner: Nielsen, Niels M. · Inventors: Nielsen, Niels M.; Bundgaard, Hans

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Compounds of the formula I, wherein R-COO- represents the acyloxy residue of a carboxylic acid drug or medicament, n is an integer from 1 to 3 and, R1 and R2 are the same or different and are selected from a group consisting of an alkyl group, an alkenyl group an aryl group, an, aralkyl group, a cycloalkyl group in which the alkyl, alkenyl, aryl, aralkyl or cycloalkyl group is unsubstituted or substituted with one or more substituents selected from:, - a halogen atom - a hydroxy group, - a carbonyl group, a straight or branched-chain alkoxy group having the formula R3-O-, wherein R3 represents an alkyl group or an aryl group which groups may be unsubstituted or substituted with one or more …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted December 21, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended December 21, 2010.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 26, 1987
GrantedDecember 21, 1993
Term endedDecember 21, 2010
Patent numberCA 1325422 C
Classification (IPC)A61K31/00 +2 more

Timeline

Timeline From CIPO dates

19881991199419972000200320062009Application filedAug 26, 1987Patent grantedDec 21, 1993Term endedDec 21, 2010

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.